Alma
Rosalind (Mowitt) Bonnat has a diverse work experience in the field of brand marketing and strategy. Rosalind is currently the Director of Brand Marketing at Alma, a position they have held since December 2021. Prior to their current role, Rosalind served as a Strategy Director at McCann New York from December 2020 to December 2021, and as a Senior Strategist from January 2018 to November 2020. Rosalind also worked as a Senior Planner at Ogilvy & Mather from November 2017 to January 2018, and as a Brand Planner from May 2016 to November 2017. Rosalind started their career as a Junior Strategic Planner at Razorfish Global from August 2014 to May 2016, where they had a hybrid role as a brand and experience strategist. Rosalind also gained experience as a Planning Intern at Saatchi & Saatchi X from June 2013 to August 2013, and as a Forecasting Intern at ZenithOptimedia from June 2011 to September 2012.
Rosalind (Mowitt) Bonnat completed their Bachelor of Arts degree in History and Integrated Marketing Communications from Northwestern University, where they studied from 2010 to 2014. In addition, they attended Sciences Po in 2012, focusing on International Relations and Affairs, although they did not attain a specific degree from this institution.
Alma
16 followers
At Alma, they're making it easier for consumers to access high-quality, affordable mental health care by supporting providers in building thriving private practices. They believe that when therapists have better resources, they’re able to provide better care to their clients. When a provider joins Alma, they gain access to a suite of tools that not only help them better run their business, but also grow it sustainably and develop as a provider. Their consumer experience is designed to empower people in their search for mental health care, offering multiple pathways and individualized support, if and when someone needs it. They’ve raised $40.5M from incredible investors like Insight Partners, Tusk, Primary, Optum Ventures, and First Round and were named one of Fast Company’s Most Innovative Companies in Health in 2020.